Drug Discovery World

MARCH 12, 2024

These confounding factors limit the opportunity for big pharma, especially considering the poor access to the complex small molecule pharmacophores known to have a link to the target disease and from which drug discovery programmes can be rolled out. RA: Could you discuss the concept of new-to-nature?

Small Molecule 147

Small Molecule Synthetic Chemistry Production Molecular Biology 147

DrugBaron

FEBRUARY 7, 2022

Finding small molecule drugs is much harder than finding a needle in a haystack – discovering the right arrangement of atoms to bind precisely to a protein target to elicit a particular response is a problem of vast dimensionality. Yet the situation with small molecules is even worse.

Small Molecule 100

Small Molecule Synthetic Chemistry Pharma Companies Pharmacokinetics 100

Drug Discovery World

NOVEMBER 17, 2022

It shows that the synthetic biology market was valued at US$9.5 According to SkyQuest Technology, the pharmaceutical industry is worth an estimated $2 trillion dollars and is expected to grow at 5% a year to 2025. These factors can significantly contribute to the growth of the synthetic biology market, it adds. .

Engineering 130

Engineering Molecular Biology Synthetic Chemistry DNA 130

The Pharma Data

DECEMBER 4, 2021

Working closely with AWS experts in machine learning and analytics, we aim to provide our scientists and researchers with the insights they need to help deliver medical breakthroughs that change patients’ lives,” said Andrew McKillop, Vice President of Pharmaceutical Sciences, Worldwide Research, Development, and Medical at Pfizer.

Drug Development 52

Drug Development Small Molecule Synthetic Chemistry Drugs 52

The Strateos Blog: Drug Discovery

AUGUST 16, 2021

Director of Chemistry of Strateos gave an interactive talk focused on how automated robotics and integrated software are powering self-driving labs that are revolutionizing synthetic chemistry to support medicinal chemistry workflows. Director of R&D Strategy and Vince Yeh, Ph.D., " - Vince Yeh, Ph.D.,

Synthetic Chemistry 52

Synthetic Chemistry Small Molecule Drugs Pharmaceutical Companies 52